Search results for: Category

Research excellence enhanced through Nursing Institute integration

In July 2021, Baylor Scott & White Health (BSWH) launched the Nursing Institute, a system-wide endeavor to elevate the nursing profession by strengthening research, continuing education, and professional excellence. In partnership with Baylor Scott & White Research Institute (BSWRI), the Nursing Institute is driving critical research to improve the practice of nursing and overall administering of care in the hospital environment.

Read more

Lung transplantation in the context of COVID-19-induced chronic lung disease

Editorial by Todd Grazia, MD, Chief of Transplant Pulmonology, Baylor University Medical Center

When SARS Co-V2 arrived on U.S. shores in early 2020, physicians in all specialties faced an enormous learning curve. As many have said, we didn’t know what we didn’t know about the coronavirus. Some patients seemed to skate through the infection, while others were laid up with flu-like symptoms for a few weeks, and yet others developed severe respiratory failure from ARDS and died. Pulmonologists and intensivists were tasked with caring for and trying to treat a critical patient population whose lungs seemed to be systematically attacked, and often, permanently damaged by the virus. As the pandemic continued to rage and upend lives, transplant pulmonologists faced a daunting ethical dilemma: Should we or should we not consider lung transplantation for patients with irreversible lung damage from COVID-19?

Read more

Translational research fuels discovery at Baylor Scott & White Research Institute

Baylor Scott & White Research Institute (BSWRI) is well known for its diverse research portfolio. The program actively maintains nearly 2,000 active and enrolling projects across more than 50 medical specialties each year, including initiatives supported by its translational research program. The program is focused on driving innovation by working with clinical teams across the Baylor Scott & White Health System to develop new medicines and diagnostic tests. The translational research team’s approach to discovery of “bench-to-bedside- and- back-to-bench” allows BSWRI to continue to be a major contributor to advancements in medical science.

Read more

BSWRI opens variant-focused monoclonal antibody trial with Eli Lilly

BSWRI’s most recent COVID-19 research endeavor was featured in an exclusive story published by the Dallas Morning News as well as a number of other local and national outlets. The trial examines a new monoclonal antibody, produced by Eli Lilly and AbCellera Biologics, which has been shown to neutralize all known variants of concern in early lab tests.

Read more